(Q38451314)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

9

Helmut Denk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Farid Moinfar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Murat Okcu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Oleksiy Tsybrovskyy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sigurd F Lax

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Wolfgang Weybora

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Manfred Ratschek

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Fattaneh A Tavassoli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

703-711

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12910513%20AND%20SRC:MED&resulttype=core&format=json

Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

The clinical value of multiple steroid receptor assays in breast cancer management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Prognostic value of estrogen receptors in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Estrogen receptors and breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Steroid-hormone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

The prognostic value of c-erbB2 in primary breast carcinomas: a study on 942 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Assessment of HER-2/neu Status in Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Critical determination of the frequency of c-erbB-2 amplification in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Oestrogen and androgen receptors in breast cancer and response to endocrine therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

A demonstration of androgen and estrogen receptors in a human breast cancer using a new protamine sulfate assay

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Androgen receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Androgen Receptor Assay with [3H]Methyltrienolone (R1881) in the Presence of Progesterone Receptors*

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Effects of steroids on growth of an androgen-dependent mouse mammary carcinoma in cell culture

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Mediation by the Androgen Receptor of the Stimulatory and Antiandrogenic Actions of 17β-Estradiol on the Growth of Androgen-Sensitive Shionogi Mammary Carcinoma Cells in Culture

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.11532

1 reference

7 January 2021

Metabolism of androgens by human breast tissue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Aromatization of Androgens by Human Abdominal and Breast Fat Tissue1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Overview of the pharmacology of the aromatase inactivator exemestane

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021

Recent advances in aromatase inhibitor therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11532

7 January 2021